Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


23.01.2017

1 Ann Surg Oncol
1 BMC Cancer
1 Br J Cancer
1 Breast Cancer (Auckl)
2 Breast Cancer (Dove Med Press)
1 Breast Cancer Res
3 Breast Cancer Res Treat
1 Breast J
3 Cancer Epidemiol Biomarkers Prev
3 Cancer Lett
4 Clin Breast Cancer
2 Clin Cancer Res
1 Eur J Surg Oncol
2 Int J Oncol
5 J Clin Oncol
1 J Surg Oncol
1 Lancet Oncol
5 N Engl J Med
1 Oncology (Williston Park)
1 PLoS Comput Biol
1 PLoS One
1 Proc Natl Acad Sci U S A
1 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. SCHWARTZ TL, Margenthaler JA
    Axillary Ultrasound Before Neoadjuvant Chemotherapy for Breast Cancer: Don't Discount the Benefits Yet!
    Ann Surg Oncol. 2017 Jan 17. doi: 10.1245/s10434-017-5766.
    PubMed     Text format    


    BMC Cancer

  2. VESUNA F, Bergman Y, Raman V
    Genomic pathways modulated by Twist in breast cancer.
    BMC Cancer. 2017;17:52.
    PubMed     Text format     Abstract available


    Br J Cancer

  3. BOUCHARD G, Therriault H, Geha S, Bujold R, et al
    Radiation-induced lung metastasis development is MT1-MMP-dependent in a triple-negative breast cancer mouse model.
    Br J Cancer. 2017 Jan 19. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


    Breast Cancer (Auckl)

  4. LOUSBERG L, Jerusalem G
    Safety, Efficacy, and Patient Acceptability of Everolimus in the Treatment of Breast Cancer.
    Breast Cancer (Auckl). 2017;10:239-252.
    PubMed     Text format     Abstract available


    Breast Cancer (Dove Med Press)

  5. COOK MT, Liang Y, Besch-Williford C, Hyder SM, et al
    Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells.
    Breast Cancer (Dove Med Press). 2016;9:9-19.
    PubMed     Text format     Abstract available

  6. VILLA GUZMAN JC, Espinosa J, Cervera R, Delgado M, et al
    Gastric and colon metastasis from breast cancer: case report, review of the literature, and possible underlying mechanisms.
    Breast Cancer (Dove Med Press). 2016;9:1-7.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  7. MA H, Ursin G, Xu X, Lee E, et al
    Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis.
    Breast Cancer Res. 2017;19:6.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  8. MA D, Jiang YZ, Liu XY, Liu YR, et al
    Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer.
    Breast Cancer Res Treat. 2017 Jan 16. doi: 10.1007/s10549-017-4113.
    PubMed     Text format     Abstract available

  9. ALTUNDAG K
    Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?
    Breast Cancer Res Treat. 2017 Jan 16. doi: 10.1007/s10549-017-4109.
    PubMed     Text format    

  10. RIZZOLO P, Silvestri V, Ottini L
    Retesting BRCA1/BRCA2 mutation negative male breast cancer patients using next generation sequencing technologies.
    Breast Cancer Res Treat. 2017 Jan 16. doi: 10.1007/s10549-017-4108.
    PubMed     Text format    


    Breast J

  11. FELTS JL, Zhu J, Han B, Smith SJ, et al
    An Analysis of Oncotype DX Recurrence Scores and Clinicopathologic Characteristics in Invasive Lobular Breast Cancer.
    Breast J. 2017 Jan 18. doi: 10.1111/tbj.12751.
    PubMed     Text format     Abstract available


    Cancer Epidemiol Biomarkers Prev

  12. MASKARINEC G, Jacobs S, Park SY, Haiman CA, et al
    Type 2 Diabetes, Obesity, and Breast Cancer Risk: The Multiethnic Cohort.
    Cancer Epidemiol Biomarkers Prev. 2017 Jan 13. pii: cebp.0789.2016.
    PubMed     Text format     Abstract available

  13. SCHAIRER C, Gadalla SM, Pfeiffer RM, Moore SC, et al
    Diabetes, Abnormal Glucose, Dyslipidemia, Hypertension and Risk of Inflammatory and Other Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2017 Jan 13. pii: cebp.0647.2016.
    PubMed     Text format     Abstract available

  14. AHERN TP, Sprague BL, Bissell MC, Miglioretti DL, et al
    Family history of breast cancer, breast density, and breast cancer risk in a U.S. breast cancer screening population.
    Cancer Epidemiol Biomarkers Prev. 2017 Jan 17. pii: cebp.0801.2016.
    PubMed     Text format     Abstract available


    Cancer Lett

  15. MENDOZA-RODRIGUEZ M, Romero HA, Fuentes-Panana EM, Ayala-Sumuano JT, et al
    IL-1beta induces up-regulation of BIRC3, a gene involved in chemoresistance to doxorubicin in breast cancer cells.
    Cancer Lett. 2017 Jan 13. pii: S0304-3835(17)30025.
    PubMed     Text format     Abstract available

  16. MUNZONE E, Colleoni M
    Metronomics in the neoadjuvant and adjuvant treatment of breast cancer.
    Cancer Lett. 2017 Jan 13. pii: S0304-3835(17)30026.
    PubMed     Text format     Abstract available

  17. HUANG R, Yu Y, Zong X, Li X, et al
    Monomethyltransferase SETD8 regulates breast cancer metabolism via stabilizing hypoxia-inducible factor 1alpha.
    Cancer Lett. 2017 Jan 13. pii: S0304-3835(17)30020.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  18. PEREIRA CB, Leal MF, Abdelhay ES, Demachki S, et al
    MYC Amplification as a Predictive Factor of Complete Pathologic Response to Docetaxel-based Neoadjuvant Chemotherapy for Breast Cancer.
    Clin Breast Cancer. 2016 Dec 24. pii: S1526-8209(16)30570.
    PubMed     Text format     Abstract available

  19. YAN M, Wang J, Xuan Q, Dong T, et al
    The Relationship Between Tamoxifen-associated Nonalcoholic Fatty Liver Disease and the Prognosis of Patients With Early-stage Breast Cancer.
    Clin Breast Cancer. 2016 Dec 24. pii: S1526-8209(16)30569.
    PubMed     Text format     Abstract available

  20. BENEDICT C, Thom B, Teplinsky E, Carleton J, et al
    Family-building After Breast Cancer: Considering the Effect on Adherence to Adjuvant Endocrine Therapy.
    Clin Breast Cancer. 2016 Dec 24. pii: S1526-8209(16)30567.
    PubMed     Text format     Abstract available

  21. AL-BAHLANI SM, Al-Bulushi KH, Al-Alawi ZM, Al-Abri NY, et al
    Cisplatin Induces Apoptosis Through the Endoplasmic Reticulum-mediated, Calpain 1 Pathway in Triple-negative Breast Cancer Cells.
    Clin Breast Cancer. 2016 Dec 24. pii: S1526-8209(16)30566.
    PubMed     Text format     Abstract available


    Clin Cancer Res


  22. Retraction: Effective Targeting of Triple-Negative Breast Cancer Cells by PF-4942847, a Novel Oral Inhibitor of Hsp 90.
    Clin Cancer Res. 2017;23:612.
    PubMed     Text format    

  23. AFGHAHI A, Timms KM, Vinayak S, Jensen KC, et al
    Tumor BRCA1 Reversion Mutation Arising During Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy Resistance.
    Clin Cancer Res. 2017 Jan 13. pii: clincanres.2174.2016.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  24. CURTIT E, Mansi L, Maisonnette-Escot Y, Sautiere JL, et al
    Prognostic and predictive indicators in early-stage breast cancer and the role of genomic profiling: Focus on the Oncotype DX(R) Breast Recurrence Score Assay.
    Eur J Surg Oncol. 2016 Dec 14. pii: S0748-7983(16)31037.
    PubMed     Text format     Abstract available


    Int J Oncol

  25. GUERRIERO E, Sorice A, Capone F, Storti G, et al
    Combining doxorubicin with a phenolic extract from flaxseed oil: Evaluation of the effect on two breast cancer cell lines.
    Int J Oncol. 2017;50:468-476.
    PubMed     Text format     Abstract available

  26. LANGO-CHAVARRIA M, Chimal-Ramirez GK, Ruiz-Tachiquin ME, Espinoza-Sanchez NA, et al
    A 22q11.2 amplification in the region encoding microRNA-650 correlates with the epithelial to mesenchymal transition in breast cancer primary cultures of Mexican patients.
    Int J Oncol. 2017;50:432-440.
    PubMed     Text format     Abstract available


    J Clin Oncol

  27. SUPPLI NP, Johansen C, Kessing LV, Toender A, et al
    Survival After Early-Stage Breast Cancer of Women Previously Treated for Depression: A Nationwide Danish Cohort Study.
    J Clin Oncol. 2017;35:334-342.
    PubMed     Text format     Abstract available

  28. HOLMES MD, Wang J, Hankinson SE, Tamimi RM, et al
    Protein Intake and Breast Cancer Survival in the Nurses' Health Study.
    J Clin Oncol. 2017;35:325-333.
    PubMed     Text format     Abstract available

  29. VAN DEN BOGAARD VA, Ta BD, van der Schaaf A, Bouma AB, et al
    Validation and Modification of a Prediction Model for Acute Cardiac Events in Patients With Breast Cancer Treated With Radiotherapy Based on Three-Dimensional Dose Distributions to Cardiac Substructures.
    J Clin Oncol. 2017 Jan 17:JCO2016698480. doi: 10.1200/JCO.2016.69.8480.
    PubMed     Text format     Abstract available

  30. RECHT A
    Radiation-Induced Heart Disease After Breast Cancer Treatment: How Big a Problem, and How Much Can-and Should-We Try to Reduce It?
    J Clin Oncol. 2017 Jan 17:JCO2016714113. doi: 10.1200/JCO.2016.71.4113.
    PubMed     Text format    

  31. DEL MASTRO L
    Optimal Adjuvant Chemotherapy Regimens for Patients With Early-Stage Breast Cancer.
    J Clin Oncol. 2017 Jan 17:JCO2016682393. doi: 10.1200/JCO.2016.68.2393.
    PubMed     Text format    


    J Surg Oncol

  32. YIP CH
    Palliation and breast cancer.
    J Surg Oncol. 2017 Jan 18. doi: 10.1002/jso.24560.
    PubMed     Text format     Abstract available


    Lancet Oncol

  33. BURKI TK
    Incidence of breast cancer in women with type 2 diabetes.
    Lancet Oncol. 2016;17:e523.
    PubMed     Text format    


    N Engl J Med

  34. DE GRAMONT A, Herrera A, de Gramont A
    Ribociclib for HR-Positive, Advanced Breast Cancer.
    N Engl J Med. 2017;376:288.
    PubMed     Text format    

  35. HARRINGTON D, Parmigiani G
    Adaptive Randomization of Neratinib in Early Breast Cancer.
    N Engl J Med. 2016;375:1593-4.
    PubMed     Text format    

  36. JOENSUU H
    Adaptive Randomization of Neratinib in Early Breast Cancer.
    N Engl J Med. 2016;375:1592.
    PubMed     Text format    


  37. Ribociclib for HR-Positive, Advanced Breast Cancer.
    N Engl J Med. 2017;376:289.
    PubMed     Text format    

  38. ARAKI K, Miyoshi Y
    Ribociclib for HR-Positive, Advanced Breast Cancer.
    N Engl J Med. 2017;376:288.
    PubMed     Text format    


    Oncology (Williston Park)

  39. IYER P, Jasem J, Springer MA, Klein CE, et al
    PALB2-Positive Breast Cancer in a 40-Year-Old Man.
    Oncology (Williston Park). 2017;31.
    PubMed     Text format    


    PLoS Comput Biol

  40. ANDREWS E, Wang Y, Xia T, Cheng W, et al
    Contextual Refinement of Regulatory Targets Reveals Effects on Breast Cancer Prognosis of the Regulome.
    PLoS Comput Biol. 2017;13:e1005340.
    PubMed     Text format     Abstract available


    PLoS One

  41. THIRUKKUMARAN C, Shi ZQ, Thirukkumaran P, Luider J, et al
    PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer.
    PLoS One. 2017;12:e0168233.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  42. TUNG B, Schade B, Cardiff RD, Aina OH, et al
    beta-Catenin haploinsufficiency promotes mammary tumorigenesis in an ErbB2-positive basal breast cancer model.
    Proc Natl Acad Sci U S A. 2017 Jan 17. pii: 201610383.
    PubMed     Text format     Abstract available


    Radiother Oncol

  43. LEE J, Hua KL, Hsu SM, Lin JB, et al
    Development of delineation for the left anterior descending coronary artery region in left breast cancer radiotherapy: An optimized organ at risk.
    Radiother Oncol. 2017 Jan 10. pii: S0167-8140(16)34481.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: